Keith Dredge

The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells

Christine Galustian, B Meyer, Marie‐Christine Labarthe et al. · Cancer Immunology Immunotherapy · 2008 · 384 citations · Full text

Anti-cancer Agents, Cancer Immunosurveillance, Medicine +10

Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects

Keith Dredge, J B Marriott, Claire Macdonald et al. · British Journal of Cancer · 2002 · 291 citations · Full text

Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro

Keith Dredge, Rebecca Horsfall, Simon P. Robinson et al. · Microvascular Research · 2005 · 268 citations

Inflammation, Angiogenesis, Medicine +10

PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models

Keith Dredge, Edward Hammond, Paul Handley et al. · British Journal of Cancer · 2011 · 165 citations · Full text

Protective Antitumor Immunity Induced by a Costimulatory Thalidomide Analog in Conjunction with Whole Tumor Cell Vaccination Is Mediated by Increased Th1-Type Immunity

Keith Dredge, J B Marriott, Stephen Todryk et al. · The Journal of Immunology · 2002 · 165 citations · Full text